MARKET

ENOB

ENOB

Enochian Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.920
+0.160
+4.26%
Closed 16:00 07/10 EDT
OPEN
3.820
PREV CLOSE
3.760
HIGH
3.990
LOW
3.820
VOLUME
55.91K
TURNOVER
--
52 WEEK HIGH
13.43
52 WEEK LOW
1.950
MARKET CAP
182.27M
P/E (TTM)
187.56
1D
5D
1M
3M
1Y
5Y

ENOB News

More
Kiniksa Positive COVID-19 Data And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 06/10 08:59
Here's Why Small-Cap Biopharma Enochian Is Surging Higher
Shares of Enochian Biosciences Inc (NASDAQ: ENOB) were trading more than 75% higher Monday in reaction to the company's announcement regarding
Benzinga · 06/08 16:23
CHK, RIG among premarket gainers
Seeking Alpha - Article · 06/08 13:13
Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV
GlobeNewswire · 06/08 12:30
Enochian Biosciences up big on advancement of potential HIV cure
Seeking Alpha - Article · 06/08 12:20
Enochian BioSciences Announces Its Completion Of FDA INTERACT Meeting For Potential HIV Cure
Company encouraged by strong alignment with views of FDA’s CBER regarding ENOB-HV-01 LOS ANGELES, June 08, 2020 (GLOBE NEWSWIRE) -- (NASDAQ:ENOB) - Enochian BioSciences, Inc., a company focused on gene-modified
Benzinga · 06/08 11:31
MacroGenics Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 05/16 13:53
60 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares surged 71.1% to close at $15.21 on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/15 08:53

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About ENOB

Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic (producing immunologic tolerance) dendritic cell (TDC) (pre-clinical stage in Denmark), and Melvaccine (MV), a melanoma cell lysate used as standalone vaccine (pre-clinical state in Denmark). The Company offers MCV platform technology, which is a cellular immunotherapy for treatment of cancer. Also, the Company develops gene therapies for patients with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS).
More

Webull offers kinds of Enochian Biosciences Inc stock information, including NASDAQ:ENOB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENOB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENOB stock methods without spending real money on the virtual paper trading platform.